Prescription Drugs
US Congress 116th Congress
Prescription Drug STAR Act Prescription Drug Sunshine, Transparency, Accountability and Reporting Act [HB-2113]
Establishes requirements for prescription drug manufacturers to provide certain information about pricing, discounts, and product samples of applicable drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to annually determine whether there are price increases of a certain threshold for outpatient prescription drugs covered under Medicare, excluding low-cost drugs.Manufacturers must provide HHS with an explanation for drug prices that (1) cumulatively increase by at least 10% or $10,000 over one year; (2) cumulatively
(continued...)
Sponsored by: Rep. Jamie Raskin
Reported (amended) By The Committee On Ways And Means. H. Rept. 116-688, Part I. on 12/24/2020
Spread the world
Gettr US Congress 116th Congress
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act [HB-2115]
Requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements. The bill also provides statutory authority for certain provisions of the CMS rule titled "Modernizing Part D and Medicare Advantage
(continued...)
Sponsored by: Rep. Brendan Boyle
Received In The Senate And Read Twice And Referred To The Committee On Finance. on 10/29/2019
Spread the world
US Congress 116th Congress
Second Chance at Life Act of 2019 [HB-2010]
Requires abortion providers administering chemical abortions to provide specified information about the possibility of reversing the effects of such procedure. Specifically, a patient must be informed at least 24 in advance that (1) reversing a chemical abortion may be possible after administering the first drug of a two-drug procedure and (2) additional information about chemical abortions is available through the Department of Health and Human Services.Further, after the first drug is administered, the physician must provide written discharge
(continued...)
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 04/02/2019
Spread the world
US Congress 116th Congress
Medicare-X Choice Act of 2019 [HB-2000]
Establishes and funds the Medicare Exchange health plan, which allows individuals who are not otherwise eligible for Medicare to enroll in a government-administered health insurance plan. The Centers for Medicare & Medicaid Services (CMS) must offer such plan in certain individual health insurance exchanges beginning plan year 2021 and offer it in all individual health insurance exchanges beginning plan year 2024. CMS must offer the plan in the small group market in all geographic areas for plan year 2025. The plan must meet the same requirements,
(continued...)
Sponsored by: Rep. Mike Quigley
Subcommittee Hearings Held. on 12/10/2019
Spread the world
US Congress 116th Congress
Overdose Prevention and Patient Safety Act [HB-2062]
More closely aligns the federal privacy standards for substance use disorder (SUD) patient records with the standards under the Health Insurance Portability and Accountability Act (HIPAA). Specifically, the bill authorizes the disclosure of SUD patient records without a patient's written consent to: (1) a covered entity for the purposes of treatment, payment, and health care operations, as long as the disclosure is made in accordance with HIPAA; and (2) a public health authority, as long as the content of the disclosure meets HIPAA standards regarding
(continued...)
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Health. on 04/04/2019
Spread the world
US Congress 116th Congress
A resolution expressing the sense of the Senate that the Department of Justice should reverse its position in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.). [SR-134]
This resolution urges the Department of Justice (DOJ) to reverse its position in Texas v. United States. (On March 25, 2019, DOJ submitted a letter to the appellate court agreeing with the lower court's decision that the Patient Protection and Affordable Care Act should be struck in its entirety).
Sponsored by: Sen. Robert Casey
Referred To The Committee On The Judiciary. (text: Cr S2192-2193) on 04/02/2019
Spread the world
US Congress 116th Congress
Fentanyl Sanctions Act [S.1044]
Establishes programs to address illicit opioid trafficking and imposes sanctions on foreign individuals and entities involved in such activities. The President shall impose sanctions on foreign individuals and entities identified as opioid traffickers or those that own, control, or supply opioid precursors. The sanctions include bans on (1) receiving loans, (2) foreign exchange transactions, (3) property transactions, and (4) certain investments that fall under U.S. jurisdiction. The President may waive sanctions on certain parties for national
(continued...)
Sponsored by: Sen. Dianne Feinstein
Committee On Banking, Housing, And Urban Affairs. Hearings Held. on 06/04/2019
Spread the world
US Congress 116th Congress
CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act [S.1033]
Requires the Centers for Medicare and Medicaid Services (CMS) to develop a public health insurance option that meets all federal plan requirements and is available on state and federal health insurance exchanges. Specifically, the CMS must offer silver and gold plans, may offer bronze plans, and must include all essential benefits, consumer protections, and cost-sharing limitations in each plan.The CMS may contract with a third party to administer the public option plans and states may establish advisory councils to make recommendations to the CMS
(continued...)
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/04/2019
Spread the world
US Congress 116th Congress
CHOICE Act Consumer Health Options and Insurance Competition Enhancement Act [HB-2085]
Requires the Centers for Medicare and Medicaid Services (CMS) to develop a public health insurance option that meets all federal plan requirements and is available on state and federal health insurance exchanges. Specifically, the CMS must offer silver and gold plans, may offer bronze plans, and must include all essential benefits, consumer protections, and cost-sharing limitations in each plan.The CMS may contract with a third party to administer the public option plans and states may establish advisory councils to make recommendations to the CMS
(continued...)
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Health. on 04/05/2019
Spread the world
US Congress 116th Congress
Drug Price Transparency Act [HB-2087]
Requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.
Sponsored by: Rep. Vern Buchanan
Subcommittee Hearings Held. on 05/21/2019
Spread the world
US Congress 116th Congress
Condemning the Trump Administration's Legal Campaign to Take Away Americans' Health Care. [HR-271]
This resolution urges the Department of Justice (DOJ) to cease its efforts against the Patient Protection and Affordable Care Act (PPACA) and reverse its position in Texas v. United States. (On March 25, 2019, DOJ submitted a letter to the appellate court agreeing with the lower court's decision that PPACA should be struck in its entirety).
Sponsored by: Rep. Barbara Lee
Considered As Unfinished Business. (consideration: Cr H3002-3003) on 04/03/2019
Spread the world
US Congress 116th Congress
Preserving Patient Access to Compounded Medications Act of 2019 [HB-1959]
To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding pharmacies, and for other purposes.
Sponsored by: Rep. Andy Biggs
Referred To The Subcommittee On Health. on 03/29/2019
Spread the world
US Congress 116th Congress
Understanding Appropriate Alzheimer’s Care Act of 2019 [HB-1955]
Requires the Centers for Medicare & Medicaid Services to report on the appropriateness of antipsychotic prescriptions in settings other than nursing homes, particularly with respect to individuals with Alzheimer's disease.
Sponsored by: Rep. Ann Kuster
Referred To The Subcommittee On Health. on 03/29/2019
Spread the world
US Congress 116th Congress
Allowing Greater Access to Safe and Effective Contraception Act [S.930]
Permits health savings accounts, medical savings accounts, and employer reimbursements for medications to be used for over-the-counter drugs. The bill also removes the limit on employee contributions to flexible spending accounts offered under specified health plans established pursuant to a pretax salary reduction agreement with an employer (i.e., cafeteria plans). Further, the bill requires the Food and Drug Administration to give priority review, at no cost, to applications for modifications to already-approved contraceptive drugs that are intended
(continued...)
Sponsored by: Sen. Cory Gardner
Read Twice And Referred To The Committee On Finance. on 03/28/2019
Spread the world
US Congress 116th Congress
Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019 [HB-1884]
Revises various requirements for private health insurance plans and associated plan-holder cost sharing. Specifically, the bill increases premium assistance for low-income households and specifies that the coverage affordability requirements for employer-sponsored plans extend to family members of employees based on the employee's required contribution as a percentage of the employee's income. Further, the bill prohibits specified agency actions that would weaken the requirements of the Patient Protection and Affordable Care Act (PPACA) with respect
(continued...)
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Health. on 03/27/2019
Spread the world
US Congress 116th Congress
Medicaid Services Investment and Accountability Act of 2019 [HB-1839]
Alters several Medicaid programs and funding provisions. (Sec. 2) The bill temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 3) The bill also establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies
(continued...)
Sponsored by: Rep. Kathy Castor
Became Public Law No: 116-16. (txt | Pdf) on 04/18/2019
Spread the world
US Congress 116th Congress
ALERT Act of 2019 Analyzing and Leveraging Existing Rx Transactions Act of 2019 [HB-1845]
Requires the Food and Drug Administration to establish an electronic system to provide pharmacists with a patient's prescription and dispensing history with respect to covered drugs (i.e., those identified as having a risk of misuse or abuse).
Sponsored by: Rep. Ann Kuster
Referred To The Subcommittee On Health. on 03/22/2019
Spread the world
US Congress 116th Congress
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. [HR-242]
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.
Sponsored by: Rep. Gus Bilirakis
Referred To The Subcommittee On Health. on 03/19/2019
Spread the world
US Congress 116th Congress
Insurance Fairness for First Responders Act of 2019 [HB-1832]
Prohibits an issuer of life insurance from discriminatory treatment of a first responder or a health care professional on the basis of their lawful possession of naloxone, which is an opioid overdose reversal drug.
Sponsored by: Rep. Eleanor Norton
Introduced In House on 03/18/2019
Spread the world
US Congress 116th Congress
Payment Commission Data Act of 2019 [HB-1781]
Allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Sponsored by: Rep. Gerald Connolly
Received In The Senate And Read Twice And Referred To The Committee On Finance. on 10/29/2019